<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data</article-title>
</title-group>
